US generic drug make Mylan MYL is mulling a bid for Sweden's Meda, according to Financial Times. Sources report Mylan has hired adivsors to help put together a deal, which would create a $23 billion pharmaceutical company.
View full article http://www.ft.com/intl/cms/s/0/24aababc-bb78-11e3-8d4a-00144feabdc0.html#axzz2xuU35ONe
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in